Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey I Silberzweig, MD
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Loma Linda University Children'S Hospital
Loma Linda, California, United States
Recruiting - Cedars Sinai Medical Center
Los Angeles, California, United States
Recruiting - Nemours/a.I. Dupont Hospital for Children
Wilmington, Delaware, United States
Recruiting - Nemours Children'S Health
Orlando, Florida, United States
Terminated - Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
Recruiting - University of Minnesota
Minneapolis, Minnesota, United States
Recruiting - Weill Cornell Medical Center / Newyork-Presbyterian
New York, New York, United States
Recruiting - University of North Carolina
Chapel Hill, North Carolina, United States
Recruiting - Akron Children'S Hospital
Akron, Ohio, United States
Recruiting - St. Christopher'S Hospital for Children
Philadelphia, Pennsylvania, United States
Recruiting - Medical University of South Carolina Children'S Hospital
Charleston, South Carolina, United States
Recruiting - Children'S Hospital of Richmond at Vcu
Richmond, Virginia, United States
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 May 2015
- Primary completion
- 3 May 2026
- Completion
- 3 Jul 2028
- Last update posted
- 30 Apr 2025
- Registered enrollment
- 35
- Registry id
- NCT02235857
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.